,:BioCog

Florian Lammers-Lietz1, Friedrich Borchers, Insa Feinkohl

  • 1From the Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (FL-L, FB, CK, HK, JS, CS, GW), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin (IF), Faculty of Health at Department of Medicine, Witten/Herdecke University, Witten/Herdecke (IF), Molecular Physiology & Cell Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Berlin (CK), Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine, Universitätsmedizin Greifswald, Greifswald (GL), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology (JW), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Metabolomics Platform (JW), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) (MW), Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (MW, FP), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin (MW, FP), Pharmaimage Biomarker Solutions GmbH, Berlin, Germany (GW), and Pharmaimage Biomarker Solutions Inc., Cambridge, Massachusetts, USA (GW).

PubMed
まとめ

術後の認知機能不全 (POCD) は,脳の接続性の変化と関連しています. ベントラル・テグメンタル領域と黒い物質のドーパミナージックネットワークの変化は,POCDのリスクを増やす可能性があります.